Marchantin A Trimethyl Ether: Its Molecular Structure and Tubocurarine-like Skeletal Muscle Relaxation Activity

Chemical and Pharmaceutical Bulletin

Volumn 42, Issue 1, 1994, Pages 52-56

  Taira, Zenei ^a   Takei, Masao ^a   Endo, Koiti ^a   Hashimoto, Toshihiro ^a   Sakiya, Yoko ^a   Asakawa, Yoshinori ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

crystal structure; d tubocurarine; marchantin A trimethyl ether; O,O ,N trimethyltubocurarine; skeletal muscle relaxation activity

Indexed keywords

ACETYLCHOLINE; MARCHANTIN A; NICOTINE; TUBOCURARINE ALKALOID; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG STRUCTURE; FROG; MUSCLE RELAXATION; NONHUMAN; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

ANIMAL; BIBENZYLS; CRYSTALLOGRAPHY, X-RAY; ETHERS, CYCLIC; IN VITRO; MUSCLE RELAXANTS, CENTRAL; MUSCLE RELAXATION; MUSCLES; RANIDAE; TUBOCURARINE;

EID: 0028118717     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.42.52     Document Type: Article

References (22)

1. Y. Asakawa, R. Matsuda, M. Toyata, C. Suire, T. Takemoto, R. Inoue, S. Hattori, M. Mizutani, J. Hattori Bot. Lab., 50, 165 (1981).
2. Y. Asakawa, M. Toyota, Z. Taira, T. Takemoto, M. Kido, J. Org. Chem., 48, 2164 (1983).
3. Y. Asakawa, M. Toyota, R. Matsuda, K. Takikawa, T. Takemoto, Phytochemistry, 22, 1413 (1983).
4. Y. Asakawa, J. Hattori Bot. Lab., 56, 215 (1984).
5. Y. Asakawa, M. Tori, K. Takikawa, H. G. Krishnamurty, S. K. Kar, Phytochemistry, 26, 1811 (1987).
6. M. Toyota, Thesis, Tokushima Bunri University, Tokushima, Japan, 1987, p. 9.
7. A. J. Everett, L. A. Lowe, S. Wilkinson, J. Chem. Soc., Chem. Commun., 1970, 1020.
8. M. M. Smith, “Drug Design,” Vol. II, ed. by A. Arien, Academic Press, New York and London, 1971, p. 503.
9. P. Taylor, “The Pharmacological Basis of Therapeutics,” 7th ed., ed. by A. G. Gilman, L. S. Goodman, T. W. Rail, F. Murad, Macmillan Publishing Co., New York, 1985, Chap. 11, p. 222.
10. D. Colquhoun, F. Dreyer, R. F. Sheridan, J. Physiol., 293, 247 (1979).
11. P. Culver, M. Burch, C. Potenza, L. Wasserman, W. Fenical, P. Taylor, Mol. Pharmacol., 28, 436 (1985).
12. P. W. Codding, M. N. G. James, J. Chem. Soc., Chem. Commun., 1972, 1174.
13. C. D. Reynolds, R. A. Palmer, Acta Cryst., B32, 1431 (1976).
14. H. M. Sobell, T. D. Sakore, S. S. Tavale, F. G. Canepa, P. Pauling, T. J. Petcher, Proc. Natl. Acad. Sci. U.S.A., 69, 2212 (1972).
15. P. Main, L. Lessinger, M. M. Woolfsom, G. Germain, J. P. Declercq, MULTAN 77, A Program for the Automatic Solution of Crystal Structure from X-Ray Diffraction Data, University of York, England, 1977.
16. D. T. Cromer, J. T. Waber, International Tables for X-Ray Crystallography, Vol. IV, ed. by J. A. Ibers, W. C. Hamilton, Kynoch Press, Birmingham, 1974, p. 71.
17. H. Moritoki, M. Takei, M. Kotani, Y. Kiso, Y. Ishida, K. Endo, Eur. J. Pharmacol., 100, 29 (1984).
18. R. S. Egan, R. S. Stanaszek, D. E. Williamson, J. Chem. Soc., Perkin Trans. 2, 1973, 716.
19. L. Koike, A. J. Marsaioli, F. de A. M. Reis, J. Org. Chem., 46, 2385 (1981).
20. J. M. van Rossum, Arch. Int. Pharmacodyn., 143, 299 (1963).
21. J. M. Bowen, J. Pharmacol. Exp. Ther., 183, 333 (1972).
22. E. F. van Maanen, J. Pharmacol. Exp. Ther., 99, 255 (1950).